Sequence-specific suppression of mdr1a/1b expression in mice via RNA interference

Area of Science:

• Molecular Biology
• Genetics
• Pharmacology

Background:

• RNA interference (RNAi) is a key mechanism for post-transcriptional gene silencing.
• P-glycoprotein (P-gp), encoded by mdr1a/1b genes, plays a crucial role in drug transport and multidrug resistance.
• Developing efficient in vivo RNAi strategies is essential for therapeutic applications.

Purpose of the Study:

• To investigate the efficacy of in vivo RNAi for silencing endogenous mdr1a/1b genes in adult mice.
• To assess the feasibility of generating P-glycoprotein (P-gp) knockdown mice using simple intravenous delivery of small interfering RNA (siRNA) or siRNA-expressing plasmid DNA.

Main Methods:

• In vitro screening of targeted sequences for mdr1a and mdr1a/1b silencing in colon26 cells.
• Hydrodynamics-based intravenous injection of synthetic siRNAs or siRNA-expressing plasmid DNAs in mice.
• Quantification of mdr1a/1b mRNA and P-gp protein levels in the liver using real-time PCR and Western blot.

Main Results:

• Optimized siRNA sequences successfully reduced mdr1a mRNA levels by 50-60% in mouse liver.
• A modest reduction in P-gp protein levels was observed following siRNA administration.
• Similar gene silencing effects were achieved using siRNA-expressing plasmid DNA targeting mdr1a/1b.

Conclusions:

• Sequence-specific suppression of mdr1 gene expression is achievable in vivo.
• Intravenous delivery of siRNA effectors can lead to both mRNA and protein level reduction of mdr1.
• This study demonstrates a viable approach for generating P-gp knockdown mice via RNAi.